Trading on the TSX Venture, Ventripoint Diagnostics (CVE: VPT) or symbol ‘VPT’, is all about the heart. Heart disease is the leading cause of deaths for both men and women worldwide. In addition, US$200 Billion is spent on cardiovascular diseases in just US alone on an annual basis – with US$1.4 billion spent on echocardiogram machines each year. On that note, the current 2D echocardiogram is the most commonly-used cardiac diagnostic tool world-wide. But there are a few problems with it:

1. It does not obtain accurate and reliable volumes for any heart chamber
2. The machine does not measure the right ventricle (RV) volume & ejection fraction in children
3. Lastly, its tedious to work on difficult to scan patients (ie: obese)

Even the in-depth MRI scan has its own set of problems – costly, less efficient and often requires sedation of patients. Luckily, there is a solution to all that....